Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NewAmsterdam Pharma Company N.V. Ordinary Shares
NAMS | US
30.77
USD0.91
3.05%
NAMS | US
Loading StockChartView...
About NewAmsterdam Pharma Company N.V. Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
30.77
Open
29.64
High
30.80
Low
29.35
NewAmsterdam Pharma Company N.V. a clinical-stage biopharmaceutical company develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib a next generation oral and low-dose cholesteryl ester transfer protein (CETP) inhibitor that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden the Netherlands.
View LessNAMS | US
Risk
50.7
Sharpe
0.46
Luna's Score
57/100
Recommendation
Hold
Luna says (NAMS | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
60.9%1 month
50.7%3 months
47.1%6 months
57.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.47
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
27.63
Ent. to rev.
175.59
PEG
-
Other Fundamentals
EBITDA
-208.63M
MarketCap
2.77B
MarketCap(USD)
2.77B
Div. yield
-
Op. margin
-2.31K
Erngs. growth
-
Rev. growth
32.70
Ret. on equity
-54.08
Short ratio
1.84
Short perc.
0.83
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
7.88
Range1M
8.76
Range3M
8.76
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.88
Price X volume
23.42M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 27.63 | 0.53 | Expensive |
| Ent. to Revenue | 175.59 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.47 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 47.08 | 72.80 | Lower Risk |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 2.77B | 3.66B | Emerging |
